Financials Thomson Medical Group Limited Deutsche Boerse AG
Equities
3H5
SG1M49904634
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0325 EUR | 0.00% |
|
0.00% | -17.72% |
Jul. 09 | Thomson Medical Group Launches SG$45.0 Million Bonds | MT |
Jul. 08 | Thomson Medical Group Limited Launches and Prices 5.50% Notes Due 2028 | CI |
Valuation
Fiscal Period: June | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Capitalization 1 | 1,560 | 1,322 | - | - |
Enterprise Value (EV) 1 | 1,560 | 2,269 | 2,242 | 2,207 |
P/E ratio | 42.8 x | 50 x | 50 x | 25 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | 3.28 x | 2.82 x | 2.63 x |
EV / Revenue | - | 5.62 x | 4.79 x | 4.38 x |
EV / EBITDA | - | 21.1 x | 16.9 x | 15.5 x |
EV / FCF | - | -6.06 x | 20.5 x | 22 x |
FCF Yield | - | -16.5% | 4.87% | 4.55% |
Price to Book | - | 2.51 x | 2.35 x | 2.17 x |
Nbr of stocks (in thousands) | 26,441,067 | 26,441,067 | - | - |
Reference price 2 | 0.0590 | 0.0500 | 0.0500 | 0.0500 |
Announcement Date | 8/28/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Net sales 1 | - | 403.6 | 468.3 | 503.6 |
EBITDA 1 | - | 107.5 | 133 | 142.5 |
EBIT 1 | - | 83.85 | 105.6 | 112.6 |
Operating Margin | - | 20.77% | 22.55% | 22.35% |
Earnings before Tax (EBT) 1 | - | 39.4 | 60.9 | 68.9 |
Net income 1 | 36.56 | 20 | 36.6 | 42.5 |
Net margin | - | 4.95% | 7.82% | 8.44% |
EPS 2 | 0.001380 | 0.001000 | 0.001000 | 0.002000 |
Free Cash Flow 1 | - | -374.1 | 109.2 | 100.4 |
FCF margin | - | -92.68% | 23.32% | 19.94% |
FCF Conversion (EBITDA) | - | - | 82.11% | 70.46% |
FCF Conversion (Net income) | - | - | 298.36% | 236.24% |
Dividend per Share 2 | - | - | - | - |
Announcement Date | 8/28/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|
Net Debt 1 | - | 947 | 920 | 884 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | - | 8.805 x | 6.916 x | 6.207 x |
Free Cash Flow 1 | - | -374 | 109 | 100 |
ROE (net income / shareholders' equity) | - | 4.65% | 6.9% | 7.75% |
ROA (Net income/ Total Assets) | - | 1.45% | 2% | 2.3% |
Assets 1 | - | 1,379 | 1,830 | 1,848 |
Book Value Per Share 2 | - | 0.0200 | 0.0200 | 0.0200 |
Cash Flow per Share 2 | - | 0 | 0 | 0 |
Capex 1 | - | 519 | 32.1 | 30.8 |
Capex / Sales | - | 128.58% | 6.85% | 6.11% |
Announcement Date | 8/28/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.84% | 83.16B | |
-25.24% | 73.08B | |
-1.34% | 26.15B | |
+4.56% | 17.9B | |
-9.29% | 17.39B | |
+4.52% | 15.94B | |
+78.16% | 13.61B | |
+77.84% | 13.06B | |
-26.14% | 12.76B |
- Stock Market
- Equities
- A50 Stock
- 3H5 Stock
- Financials Thomson Medical Group Limited